Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Garcia-Del-Muro X, P Valderrama B, Medina-Colmenero A, Etxaniz O, et al. Bladder Preservation with Durvalumab plus Tremelimumab and Concurrent Radiotherapy in Patients with Localized Muscle-Invasive Bladder Cancer (IMMUNOPRESERVE): A Phase II Spanish Oncology GenitoUrinary Group Trial. Clin Cancer Res 2025;31:659-666.
PMID: 39957401


Privacy Policy